(E)-1-cyclopropyl-4-(4-fluorophenyl)-3-[4-(4-hydroxy-3-oxobutyl)phenyl]but-3-en-2-one
C23H23FO3 — CID 158073354
Data last refreshed: (MolForge compound catalog, from PubChem)
About (E)-1-cyclopropyl-4-(4-fluorophenyl)-3-[4-(4-hydroxy-3-oxobutyl)phenyl]but-3-en-2-one
(E)-1-cyclopropyl-4-(4-fluorophenyl)-3-[4-(4-hydroxy-3-oxobutyl)phenyl]but-3-en-2-one (PubChem CID 158073354) has the molecular formula C23H23FO3 and a molecular weight of 366.43 g/mol. Its IUPAC name is (E)-1-cyclopropyl-4-(4-fluorophenyl)-3-[4-(4-hydroxy-3-oxobutyl)phenyl]but-3-en-2-one.
Molecular Properties
| Compound Name | (E)-1-cyclopropyl-4-(4-fluorophenyl)-3-[4-(4-hydroxy-3-oxobutyl)phenyl]but-3-en-2-one |
|---|---|
| PubChem CID | 158073354 |
| Molecular Formula | C23H23FO3 |
| Molecular Weight | 366.43 g/mol |
| Exact Mass | 366.16 |
| IUPAC Name | (E)-1-cyclopropyl-4-(4-fluorophenyl)-3-[4-(4-hydroxy-3-oxobutyl)phenyl]but-3-en-2-one |
| SMILES | O=C(CO)CCc1ccc(/C(=C\c2ccc(F)cc2)C(=O)CC2CC2)cc1 |
| InChI | InChI=1S/C23H23FO3/c24-20-10-5-17(6-11-20)13-22(23(27)14-18-1-2-18)19-8-3-16(4-9-19)7-12-21(26)15-25/h3-6,8-11,13,18,25H,1-2,7,12,14-15H2/b22-13+ |
| InChIKey | CESVFSYXXLLSGC-LPYMAVHISA-N |
| XLogP | 4.23 |
| TPSA | 54.37 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 3 |
| Rotatable Bonds | 9 |
| Heavy Atoms | 27 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 366.43 |
| LogP ≤ 5 | 4.23 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 3 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Michael_acceptor_1', 'substructure': 'N/A'}, {'alert_name': 'stilbene', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 158073354 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.